Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Neurology

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ene.13206PMID 27888574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder.

  2016cited by this paper
• Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson’s Disease

  2016cited by this paper
• (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.

  2015cited by this paper
• New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.

  2015cited by this paper
• The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study)

  2015cited by this paper
• Chronological changes of 123I-MIBG myocardial scintigraphy and clinical features of Parkinson's disease

  2015influential reference
• Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

  2015cited by this paper
• Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease

  2015cited by this paper
• 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review

  2015cited by this paper
• Multiple organ involvement by alpha‐synuclein pathology in Lewy body disorders

  2014cited by this paper
• The pathomechanisms underlying Parkinson's disease

  2014cited by this paper
• Neuropathology of prodromal Lewy body disease

  2014cited by this paper
• Parkinson's Disease Mild Cognitive Impairment: Application and Validation of the Criteria

  2014cited by this paper
• Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.

  2014cited by this paper
• Premotor and nonmotor features of Parkinson's disease.

  2014cited by this paper
• MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.

  2014cited by this paper
• Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

  2013cited by this paper
• REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease

  2013cited by this paper
• Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

  2013cited by this paper
• Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms

  2013cited by this paper
• Caudo-rostral brain spreading of α-synuclein through vagal connections

  2013cited by this paper
• Questionnaire‐based diagnosis of REM sleep behavior disorder in Parkinson's disease

  2013cited by this paper
• EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease

  2013cited by this paper
• Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson’s disease?

  2013cited by this paper
• Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease

  2012cited by this paper
• Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease

  2012cited by this paper
• 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.

  2012cited by this paper
• Validation of the Korean-Version of the Nonmotor Symptoms Scale for Parkinson's Disease

  2012cited by this paper
• Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort.

  2011cited by this paper
• Parkinson’s disease risk score: moving to a premotor diagnosis

  2011cited by this paper
• Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

  2011cited by this paper
• Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.

  2011cited by this paper
• Nonmotor symptoms in genetic Parkinson disease.

  2010cited by this paper
• Spinocerebellar ataxia type 12 identified in two Italian families may mimic sporadic ataxia

  2010cited by this paper
• Cardiac 123I-metaiodobenzylguanidine Scintigraphy in a Patient with Familial Parkinsonism with Parkin Gene Mutation

  2010cited by this paper
• When does Parkinson's disease begin?

  2009cited by this paper
• Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's disease.

  2009cited by this paper
• Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease

  2008cited by this paper
• Clinical diagnostic criteria for dementia associated with Parkinson's disease

  2007cited by this paper
• The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument

  2007cited by this paper
• Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease

  2005cited by this paper
• Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT

  2004cited by this paper
• Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET

  1998cited by this paper
• Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy

  1996cited by this paper
• When does Parkinson's disease begin?

  1992cited by this paper
• The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

  1990cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper

• Neuroimaging and Pathology Biomarkers in Parkinson’s Disease and Parkinsonism

  2026cites this paper
• Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson’s disease

  2025cites this paper
• Untangling the Heart-Brain Connection in Parkinson's Disease: Emerging Mechanisms and Models.

  2025cites this paper
• Olfactory Dysfunction as a Window Into the Heterogeneity of Parkinson Disease

  2025cites this paper
• MicroRNAs and synaptic dysfunction in Parkinson’s disease

  2025cites this paper
• Cardiac 123I-Meta-Iodobenzylguanidine Imaging as a Biomarker for Body-First Parkinson’s Disease: Linking Peripheral α-Synuclein to Clinical Subtyping

  2025cites this paper
• Progranulin Mutation Manifesting as Parkinson Disease: A Case Series from the PADUA‐CESNE Cohort

  2025cites this paper
• Value of extra-cardiac sympathetic nervous uptake parameters based on 123I-MIBG SPECT/CT in the assessment of Parkinson’s disease

  2025cites this paper
• Differential striatal dopamine binding in Parkinson’s Disease with and without REM sleep behavior disorder: A Tc-99 m TRODAT-1 SPECT study

  2025cites this paper
• Value of multi-parameter 123I-MIBG scintigraphy in the differential diagnosis of Parkinson’s disease

  2025cites this paper
• Fasting Plasma Glucose Levels and Longitudinal Motor and Cognitive Outcomes in Parkinson’s Disease Patients

  2024cites this paper
• Gastric emptying time and its correlation with cardiac MIBG in body-first and brain-first subtype Parkinson’s disease

  2024cites this paper
• Approaches to Early Parkinson’s Disease Subtyping

  2024cites this paper
• Unraveling olfactory subtypes in Parkinson’s disease and their effect on the natural history of the disease

  2024cites this paper
• Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome

  2024cites this paper
• Progression subtypes in Parkinson’s disease identified by a data-driven multi cohort analysis

  2024cites this paper
• Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same

  2024cites this paper
• Brain-first vs. body-first Parkinson's disease: An update on recent evidence.

  2024cites this paper
• Estimating motor progression trajectory pursuant to temporal dynamic status of cardiac denervation in Parkinson’s disease

  2024influential citation
• Heart-rate variability as a new marker for freezing predisposition in Parkinson's disease.

  2023cites this paper
• Correlation of olfactory function factors with cardiac sympathetic denervation in Parkinson’s disease

  2023cites this paper
• Cardiac sympathetic “morbidity” might reflect the neurobiology of early Parkinson’s disease

  2023cites this paper
• Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review

  2023cites this paper
• Exploring the link between essential tremor and Parkinson’s disease

  2023cites this paper
• The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models

  2023cites this paper
• What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies?

  2022cites this paper
• Body-first Parkinson's disease and variant Creutzfeldt-Jakob disease - similar or different?

  2022cites this paper
• Clinical and imaging evidence of brain-first and body-first Parkinson's disease.

  2022cites this paper
• Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy

  2022cites this paper
• Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder

  2022cites this paper
• Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson’s disease

  2022cites this paper
• Comparison of disease progression between brain-predominant Parkinson's disease versus Parkinson's disease with body-involvement phenotypes.

  2022cites this paper
• Cardiovascular Autonomic Dysfunction in Idiopathic Parkinson's Disease

  2022cites this paper
• A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease

  2022cites this paper
• Striatal Dopaminergic Asymmetry as a marker of Brain-First and Body-First Subtypes in de novo Parkinson's Disease

  2022cites this paper
• Cardiac sympathetic burden reflects Parkinson disease burden, regardless of high or low orthostatic blood pressure changes

  2021cites this paper
• The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

  2021cites this paper
• Assessing autonomic dysfunction with functional imaging in Parkinson's disease

  2021cites this paper
• Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson’s disease

  2021cites this paper
• Cardiac sympathetic burden reflects Parkinson disease burden, regardless of high or low orthostatic blood pressure changes

  2021cites this paper
• What Is the Clinical Correlation of Cardiac Noradrenergic Denervation in Parkinson Disease?

  2021cites this paper
• Impact of rapid eye movement sleep behavior disorder and autonomic disorders on Parkinson's disease: a review

  2020cites this paper
• Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy

  2020cites this paper
• Parkinson Disease Propagation Using MRI Biomarkers and Partial Least Squares Path Modeling

  2020cites this paper
• [18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study.

  2020cites this paper
• Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.

  2020cites this paper
• Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?

  2020cites this paper
• Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes

  2019cites this paper
• Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson’s Disease in the Early Phase?

  2019cites this paper
• Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis

  2019cites this paper
• Sensitivity and specificity of cardiac 123I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease.

  2019cites this paper
• What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.

  2019cites this paper
• Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.

  2019cites this paper
• Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease.

  2019cites this paper
• Dysautonomia is associated with structural and functional alterations in Parkinson disease

  2019influential citation
• Cardiac 123I-MIBG Scintigraphy in Neurodegenerative Parkinson Syndromes: Performance and Pitfalls in Clinical Practice

  2019cites this paper
• Cardiac Sympathetic Denervation Can Predict the Wearing-off Phenomenon in Patients with Parkinson Disease

  2018cites this paper
• Progress in neurology 2017–2018

  2018cites this paper
• Imaging the Autonomic Nervous System in Parkinson’s Disease

  2018cites this paper
• Roles of cardiac sympathetic neuroimaging in autonomic medicine

  2018cites this paper
• Autonomic Sweat Responses in REM Sleep Behavior Disorder and Parkinsonism

  2018cites this paper
• Clinical utility and research frontiers of neuroimaging in movement disorders.

  2017cites this paper
• Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.

  2017cites this paper
• Clinical Characteristics of Parkinson’s Disease Developed from Essential Tremor

  2017cites this paper
• Nonmotor Aspects of Parkinson's Disease-How Do They Help Diagnosis?

  2017cites this paper
• Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression?

  2017cites this paper
• The heart of PD: Lewy body diseases as neurocardiologic disorders.

  2017cites this paper
• Doença de Parkinson Prodrômica: O que sabemos e o que não sabemos

  year unknowncites this paper